1998
DOI: 10.1159/000026783
|View full text |Cite
|
Sign up to set email alerts
|

The Use of Photodynamic Therapy for Skin Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2000
2000
2013
2013

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 40 publications
0
4
0
Order By: Relevance
“…These photosensitized conjugates may also potentially be used as agents for photodynamic therapy (PDT) of superficial cancers such as skin cancer. 26 The hydrophilic nature of the QD conjugates makes them ideal for uptake into inflamed tissues, often a barrier to successful PDT. 27 …”
Section: Discussionmentioning
confidence: 99%
“…These photosensitized conjugates may also potentially be used as agents for photodynamic therapy (PDT) of superficial cancers such as skin cancer. 26 The hydrophilic nature of the QD conjugates makes them ideal for uptake into inflamed tissues, often a barrier to successful PDT. 27 …”
Section: Discussionmentioning
confidence: 99%
“…The substances most frequently used for PDT of skin diseases are 5-aminolaevulinic acid (ALA) and its ester, methyl aminolaevulinate (MAL). Several studies have so far proven the effectiveness of topical ALA-⁄ MAL-PDT in the treatment of AK and other superficial skin tumors (2)(3)(4)(5)(6)(7)(8)(9)(10)(11).…”
Section: Introductionmentioning
confidence: 99%
“…The technique is based on the preferential accumulation of porphyrin in tumor tissue with subsequent cytotoxicity mediated by singlet oxygen production (1). Its therapeutic usefulness is due to selective and rapid tumor necrosis after illumination of the porphyrin-containing tumor with visible light (2).…”
Section: Introductionmentioning
confidence: 99%
“…Its therapeutic usefulness is due to selective and rapid tumor necrosis after illumination of the porphyrin-containing tumor with visible light (2). Tumor necrosis seems to be preceded by significant alterations in the vascular system of the tumor (1,2). Hematoporphyrin derivative (HpD), first developed by Lipson in 1960, and a purified fraction, dihematoporphyrin ether, known as Photofrin II ® , are complex mixtures used for tumor localization and treatment (3).…”
Section: Introductionmentioning
confidence: 99%